While Endo is every bit as important medically, I don't think it will be as lucrative commercially.
The proactive monitoring, annual retest, for kidney disease is the differentiator
PIQ $1.00, page-46
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.0¢ |
Change
0.015(1.69%) |
Mkt cap ! $117.8M | |||
| Open | High | Low | Value | Volume |
| 87.5¢ | 90.0¢ | 87.5¢ | $26.27K | 29.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 177 | 88.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.0¢ | 6202 | 1 |
View Market Depth
| Last trade - 15.27pm 27/06/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |